% Expired Patents = 100.0

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 13

Loading Chart...

1 inventor (with patents filed for the assignee):

Yu Ge (5 out of 8 patents)

5 patents: Sort by Forward Citations

1. 9458151 - Isothiazole derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof (2016-10-04),

2. 9453003 - Pyrimidine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof (2016-09-27),

3. 9452995 - Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof (2016-09-27),

4. 9090594 - PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof (2015-07-28),

5. 8969584 - PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof (2015-03-03),

Company Overview

Jikai Biosciences, Inc. is a biotechnology company focused on developing innovative therapies for various medical conditions. With a team of experienced scientists and researchers, the company is dedicated to advancing the field of bioengineering and drug discovery. Jikai Biosciences is committed to improving patient outcomes through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#455 in Shanghai

#5,271 in China

Shanghai, China

Jikai Biosciences, Inc.

Forward Citations = 13

1 inventor:

Yu Ge (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jikai Biosciences, Inc.. Retrieved from https://idiyas.com/company/jikai-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]